Objectif de l'étude : notre objectif était de déterminer les seuils sériques du télopeptide C-terminal du collagène de type I (sCTX) pour prédire le risque minimal d'ostéonécrose de la mâchoire liée aux médicaments (MRONJ) chez les patients qui suivent un traitement anti-résorptif avant une chirurgie dentaire. Méthode : une recherche documentaire s...
OBJECTIVE: To identify local radiographic risk factors for Medication-Related Osteonecrosis of the Jaws (MRONJ) in osteoporotic patients treated with antiresorptive drugs (ARD) and undergoing tooth extraction. MATERIAL AND METHODS: Patients were included in this retrospective, longitudinal, case-control study, if having at least one administration ...
Published in Journal of stomatology, oral and maxillofacial surgery
Dental implants are a common solution for edentulous patients. This systematic review and meta-analysis aimed to determine whether locally delivered diphosphonates influence the osseointegration of dental implants in humans. In March 2023, we conducted an electronic systematic literature search using three databases (MEDLINE/PubMed, Embase, Web of ...
OBJECTIVES: To identify clinical and local radiographic predictors for medication-related osteonecrosis of the jaws (MRONJ) by the assessment of pre-operative CBCT images of oncologic patients treated with anti-resorptive drugs (ARDs) undergoing tooth extractions. METHODS: This retrospective, longitudinal, case-control study included clinical and i...
Published in Dento maxillo facial radiology
To identify clinical and local radiographic predictors for medication-related osteonecrosis of the jaws (MRONJ) by the assessment of pre-operative CBCT images of oncologic patients treated with anti-resorptive drugs (ARDs) undergoing tooth extractions. This retrospective, longitudinal, case-control study included clinical and imaging data of 97 pat...
peer reviewed / [en] INTRODUCTION: The objective of this systematic review and meta-analysis is to systematically identify and review the efficacy of pharmacological treatments in men with osteoporosis. METHODS: Medline (via Ovid) and Cochrane CENTRAL were searched up to May 2023 for any randomized controlled trial (RCT) evaluating the efficacy of ...
Published in Journal of bone metabolism
As the aging population increases, the number of patients with osteoporosis is gradually rising. Osteoporosis is a metabolic bone disease characterized by low bone mass and the microarchitectural deterioration of bone tissue, resulting in reduced bone strength and an increased risk of low-energy or fragility fractures. Thus, the use of anti-resorpt...
Published in The Cochrane Database of Systematic Reviews
Treatment of osteoporosis in people with beta‐thalassaemia Review question How effective and safe are different treatments for osteoporosis in people with beta‐thalassaemia? Background Osteoporosis affects bone density over time and leads to an increased risk of fractures. It is an important cause of illness in people with beta‐thalassaemia (a bloo...
This study investigated the incidence, risk factors, and outcome of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents for osteoporosis or bone metastases. 240 patients with a median drug exposure of 43 months were retrospectively studied. The incidence of MRONJ after dental extraction i...
peer reviewed / [en] BACKGROUND: Osteoporosis is often considered to be a disease of women. Over the last few years, owing to the increasing clinical and economic burden, the awareness and imperative for identifying and managing osteoporosis in men have increased substantially. With the approval of agents to treat men with osteoporosis, more econom...
